Add-on effect of Brahmi in the management of schizophrenia
- PMID: 23326095
- PMCID: PMC3545244
- DOI: 10.4103/0975-9476.104448
Add-on effect of Brahmi in the management of schizophrenia
Abstract
Brahmi(Bacopa monnieri), an Ayurvedic herb has primarily been used to enhance cognitive ability, memory and learning skills. We present a case study of schizophrenia in which add-on Brahmi extracts 500 mg/day for a period of one month resulted in reduction in psychopathology without any treatment-emergent adverse effect. Although preliminary, our case study suggests therapeutic efficacy of add-on Brahmi in schizophrenia, thus opening up a new dimension of its role in alternative medicines.
Keywords: Bacopa monnieri; Brahmi; schizophrenia.
Conflict of interest statement
Figures
Similar articles
-
Bacopa monnieri (Brahmi) improved novel object recognition task and increased cerebral vesicular glutamate transporter type 3 in sub-chronic phencyclidine rat model of schizophrenia.Clin Exp Pharmacol Physiol. 2016 Dec;43(12):1234-1242. doi: 10.1111/1440-1681.12658. Clin Exp Pharmacol Physiol. 2016. PMID: 27562725
-
Effect of traditional medicine brahmi vati and bacoside A-rich fraction of Bacopa monnieri on acute pentylenetetrzole-induced seizures, amphetamine-induced model of schizophrenia, and scopolamine-induced memory loss in laboratory animals.Epilepsy Behav. 2018 Mar;80:144-151. doi: 10.1016/j.yebeh.2017.12.040. Epub 2018 Feb 2. Epilepsy Behav. 2018. PMID: 29414544
-
Cognitive enhancement effects of Bacopa monnieri (Brahmi) on novel object recognition and neuronal density in the prefrontal cortex, striatum and hippocampus in sub-chronic phencyclidine administration rat model of schizophrenia.J Med Assoc Thai. 2015 Mar;98 Suppl 2:S56-63. J Med Assoc Thai. 2015. PMID: 26211105
-
Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer's disease.Arch Biochem Biophys. 2019 Nov 15;676:108153. doi: 10.1016/j.abb.2019.108153. Epub 2019 Oct 14. Arch Biochem Biophys. 2019. PMID: 31622587 Review.
-
Exploring the Role of “Brahmi” (Bacopa monnieri and Centella asiatica) in Brain Function and Therapy.Recent Pat Endocr Metab Immune Drug Discov. 2011 Jan;5(1):33-49. doi: 10.2174/187221411794351833. Recent Pat Endocr Metab Immune Drug Discov. 2011. PMID: 22074576 Review.
Cited by
-
Effect of pre- and post-treatment with Bacopa monnieri (Brahmi) on phencyclidine-induced disruptions in object recognition memory and cerebral calbindin, parvalbumin, and calretinin immunoreactivity in rats.Neuropsychiatr Dis Treat. 2019 May 1;15:1103-1117. doi: 10.2147/NDT.S193222. eCollection 2019. Neuropsychiatr Dis Treat. 2019. PMID: 31118643 Free PMC article.
-
Zebrafish models for studying central nervous system effects of Ayurvedic medicinal plants.J Ayurveda Integr Med. 2025 Jul-Aug;16(4):101169. doi: 10.1016/j.jaim.2025.101169. Epub 2025 Jul 7. J Ayurveda Integr Med. 2025. PMID: 40628078 Free PMC article. Review.
-
[The Indian Ayurveda medicine-a meaningful supplement to psychiatric treatment?].Nervenarzt. 2018 Sep;89(9):999-1008. doi: 10.1007/s00115-018-0538-9. Nervenarzt. 2018. PMID: 29876598 Review. German.
References
-
- Fava M. Using complementary and alternative medicines for depression. J Clin Psychiatry. 2010;71:e24. - PubMed
-
- Agrawal A, Pandey MN, Dubey GP. Management of mental deficiency by an indigenous drug, Brahmi(Bacopa monnieri) Pharmacopsychoecologia. 1993;6:1–5.
-
- Stough C, Lloyd J, Clarke J, Downey LA, Hutchison CW, Rodgers T, et al. The chronic effects of an extract of Bacopa monnieri (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology (Berl) 2001;156:481–4. - PubMed
LinkOut - more resources
Full Text Sources